Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.57 |
| ▸ | RARB | P10826 | 1/20 | 0.56 |
| ▸ | RARG | P13631 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | RXRA | P19793 | 3/20 | 0.47 |
| ▸ | RXRB | P28702 | 3/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | RXRG | P48443 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410187 | 1.00 | CYP1A2 (0.59) | CYP1A2MEN1KMT2ASRD5A2RARB | |
| SCHEMBL12648649 | 1.00 | CYP1A2 (0.59) | CYP1A2MEN1KMT2ASRD5A2RARB | |
| SCHEMBL65824 | 0.83 | SRD5A2 (0.61) | CYP1A2MEN1KMT2ASRD5A2RARB | |
| SCHEMBL29098742 | 0.83 | SRD5A2 (0.61) | CYP1A2MEN1KMT2ASRD5A2RARB | |
| SCHEMBL10604183 | 0.82 | NQO2 (0.51) | CYP1A2MEN1KMT2ACYP2D6CYP2C19 | |
| Terephthalic Acid SCHEMBL31728631 | 0.82 | TSHR (0.67) | CYP1A2MEN1KMT2ASRD5A2RARB | |
| SCHEMBL24208279 | 0.81 | BLM (0.53) | CYP1A2MEN1KMT2ATSHRCYP2D6 | |
| SCHEMBL16840188 | 0.81 | SRD5A2 (0.59) | CYP1A2MEN1KMT2ASRD5A2RARB | |
| SCHEMBL11510852 | 0.81 | CYP1A2 (0.54) | CYP1A2MEN1KMT2ASRD5A2TSHR | |
| SCHEMBL5427934 | 0.81 | BLM (0.53) | CYP1A2MEN1KMT2ATSHRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118041445-B | Space laser communication terminal based on liquid crystal polarization grating and control method thereof | 南京英田光学工程股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2023196234-A1 | METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES | GLAZIER ALAN NEIL (US) | 2023-10-12 | — | — | WO | claimed |
| US-9499862-B2 | Phospholinked dye analogs with an amino acid linker | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2016-11-22 | — | — | US | claimed |
| US-20150197794-A1 | Phospholinked Dye Analogs with an Amino Acid Linker | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2015-07-16 | — | — | US | claimed |
| US-8993737-B2 | Phospholinked dye analogs with an amino acid linker | PACIFIC BIOSCIENCES, INC. (US) | 2015-03-31 | — | — | US | claimed |
| US-20120052507-A1 | PHOSPHOLINKED DYE ANALOGS WITH AN AMINO ACID LINKER | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2012-03-01 | — | — | US | claimed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| CN-115427458-A | Transglutaminase mediated conjugation | 塔拉克治疗公司 | 2022-12-02 | — | — | CN | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-113278634-B | Novel vaccine for preventing and treating merkel cell carcinoma | 艾棣维欣(苏州)生物制药有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-111378599-B | Degradation strain capable of simultaneously degrading two isomers of chiral herbicide 2, 4-dichlorprop and microbial inoculum produced by same | 南京农业大学 | 2022-02-25 | — | — | CN | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-11-25 | — | — | US | disclosed |
| US-20100248264-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-09-30 | — | — | US | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-20070032474-A1 | Use of a compound of formula 1 for making a pharmaceutical composition | BIONDI RICARDO M | 2007-02-08 | — | — | US | disclosed |
| US-20070032474-A1 | Use of a compound of formula 1 for making a pharmaceutical composition | BIONDI RICARDO M | 2007-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052507-A1 | PHOSPHOLINKED DYE ANALOGS WITH AN AMINO ACID LINKER | CHAMP1, MTAP, INCENP | CYP1A2 4842/4885MEN1 1891/4885KMT2A 491/4885 |
| US-20070032474-A1 | Use of a compound of formula 1 for making a pharmaceutical composition | CYP7A1, UGT1A1, CYP2F1 | CYP1A2 30/4885MEN1 85/4885KMT2A 4178/4885 |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CHLSN, PTMS, SRMS | CYP1A2 4648/4885MEN1 2224/4885KMT2A 4241/4885 |
| US-20150197794-A1 | Phospholinked Dye Analogs with an Amino Acid Linker | INCENP, CHAMP1, PNKP | CYP1A2 4847/4885MEN1 3060/4885KMT2A 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.